○Yasushi Goto1, Seiji Niho2, Haruko Daga3, Sakakibara-Konishi Sakakibara-Konishi4, Hiroshi Tanaka5, Kadoaki Ohashi6, Ryo Toyozawa7, Masahiro Kotani8, Toshiaki Takahashi9, Yoshihiro Hattori10, Masahiro Morise11, Takaya Ikeda2, Shingo Matsumoto2, Kiyotaka Yoh2, Shogo Nomura12, Koichi Goto2 (1.Department of Thoracic Oncology, National Cancer Center Hospital, 2.National Cancer Center Hospital East, 3.Osaka City General Hospital, 4.Hokkaido University Hospital, 5.Niigata Cancer Center Hospital, 6.Okayama University Hospital, 7.National Hospital Organization Kyushu Cancer Center, 8.Tottori University, 9.Shizuoka Cancer Center, 10.Hyogo Cancer Center, 11.Nagoya University Graduate School of Medicine, 12.The University of Tokyo)
Session information
Oral Session
[O13] Oral Session 13 Lung Cancer / Thoracic Cancer 3(Rare gene alterations)
【E】
Sat. Feb 19, 2022 8:20 AM - 9:50 AM Room 1 (Main Hall, 1F, Kyoto International Conference Center)
Chair:Satoshi Oizumi(Department of Respiratory Medicine, National Hospital Organization Hokkaido Cancer Center),Haruyasu Murakami(Chemotherapy Center/Division of Thoracic Oncology, Shizuoka Cancer Center)
Discussant:Takehito Shukuya(Department of Respiratory Medicine, Juntendo University)
○Toyozawa Ryo1, Suresh S. Ramalingam2, Ferdinandos Skoulidis3, Ramaswamy Govindan4, Vamsidhar Velcheti5, Bob T. Li6, Benjamin Besse7, Grace K. Dy8, Dong-Wan Kim9, Martin Schuler10, Mark Vincent11, Frederick Wilson12, Joseph Park13, Juan E. Gutierrez14, Qui Tran13, Simon P. Jones13, Juergen Wolf15 (1.Division of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, 2.Winship Cancer Institute, Emory University School of Medicine, 3.University of Texas M.D. Anderson Cancer Center, 4.Alvin J. Siteman Cancer Center, Washington University School of Medicine, 5.Perlmutter Cancer Center, NYU Langone, 6.Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, 7.Gustave Roussy Institute, 8.Roswell Park Cancer Institute, 9.Seoul National University Hospital, 10.West German Cancer Center, University Hospital Essen, 11.London Regional Cancer Program, 12.Yale School of Medicine, 13.Amgen Inc, 14.Cedimed-Quiron Salud, 15.University Hospital Cologne)
○Yasushi Goto1, Bob T. Li2, Egbert F. Smit3, Kazuhiko Nakagawa4, Hibiki Udagawa5, Julien Mazières6, Misako Nagasaka7, Lyudmila Bazhenova8, Andreas N. Saltos9, Enriqueta Felip10, Jose M. Pacheco11, Maurice Pérol12, Luis Paz-Ares13, Kapil Saxena14, Ryota Shiga14, Yingkai Cheng14, Suddhasatta Acharyya14, Javad Shahidi14, David Planchard15, Pasi A. Jänne16 (1.Department of Thoracic Oncology, National Cancer Center Hospital, 2.Memorial Sloan Kettering Cancer Center, New York, NY, USA, 3.Netherlands Cancer Institute, Amsterdam, Netherlands, 4.Kindai University Hospital, Osaka, Japan, 5.National Cancer Center Hospital East, Chiba, Japan, 6.Institut Universitaire du Cancer, Toulouse, France, 7.Karmanos Cancer Institute, Detroit, MI, USA, 8.University of California San Diego Moores Cancer Center, San Diego, CA, USA, 9.Moffitt Cancer Center, Tampa, FL, USA, 10.Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology, Barcelona, Spain, 11.University of Colorado, Aurora, CO, USA, 12.Centre Léon Bérard, Lyon, France, 13.Hospital Universitario 12 de Octubre, Madrid, Spain, 14.Daiichi Sankyo, Inc., Basking Ridge, NJ, USA, 15.Gustave Roussy, Villejuif, France, 16.Dana-Farber Cancer Institute and Belfer Center for Applied Cancer Science, Boston, MA, USA)
○Masahiro Morise1, Hiroshi Sakai2, Terufumi Kato3, Shingo Matsumoto4, Toru Kumagai5, Tomohiro Sakamoto6, Takaaki Tokito7, Shinji Atagi8, Toshiyuki Kozuki9, Hiroaki Takeoka10, Kenichi Chikamori11, Naofumi Shinagawa12, Hiroshi Tanaka13, Tomonori Hirashima14, S Peter Eggleton15, Rolf Bruns16, Gordon Otto17, Paul Paik18,19 (1.Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan, 2.Department of Thoracic Oncology, Saitama Cancer Center, Kitaadachi-gun, Japan, 3.Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan, 4.Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa City, Japan, 5.Department of Respiratory Medicine, Osaka International Cancer Institute, Osaka City, Japan, 6.Department of Respiratory Medicine, Tottori University Hospital, Yonago City, Japan, 7.Department of Internal Medicine, Kurume University School of Medicine, Kurume City, Japan, 8.Department of Thoracic Oncology, NHO Kinki-Chuo Chest Medical Center, Sakai City, Japan, 9.Department of Respiratory Medicine, NHO Shikoku Cancer Center, Matsuyama City, Japan, 10.Department of Respiratory Medicine, NHO Kyushu Medical Center, Fukuoka City, Japan, 11.Department of Oncology, NHO Yamaguchi - Ube Medical Center, Ube City, Japan, 12.Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan, 13.Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata City, Japan, 14.Department of Pulmonary Oncology, Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, Habikino City, Japan, 15.Global Clinical Development, Merck Serono Limited, Feltham, UK, a subsidiary of Merck KGaA, Darmstadt, Germany, 16.Department of Biostatistics, Merck Healthcare KGaA, Darmstadt, Germany, 17.Global Clinical Development, Merck Healthcare KGaA, Darmstadt, Germany, 18.Department of Medicine, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA, 19.Department of Medicine, Weill Cornell Medical College, New York, NY, USA)
○Ryo Toyozawa1, Kaname Nosaki2, Mototugu Shimokawa3, Hidehito Horinouchi4, Masahiro Morise5, Kadoaki Ohashi6, Haruyasu Murakami7, Miyako Satouchi8, Jun Sakakibara9, Seiji Yano10, Shingo Matsumoto2, Koichi Goto2, Takashi Seto1, Kiyotaka Yoh2 (1.Department of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, 2.Department of Thoracic Oncology, National Cancer Center Hospital East, 3.Department of Biostatistics, Yamaguchi University Graduate School of Medicine, 4.Department of Thoracic Oncology, National Cancer Center Hospital, 5.Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, 6.Department of Allergy and Respiratory Medicine, Okayama University Hospital, 7.Division of Thoracic Oncology, Shizuoka Cancer Center, 8.Department of Thoracic Oncology, Hyogo Cancer Center, 9.First Department of Medicine, Hokkaido University Hospital, 10.Division of Medical Oncology, Cancer Research Institute, Kanazawa University)
○Toshio Shimizu1, Satoru Kitazono2, Edward B Garon3, Melissa L Johnson4, Aaron Lisberg3, Alexander Spira5, Noboru Yamamoto1, Rebecca S Heist6, Jacob M Sands7, Funda Meric-Bernstam8, Yoshitaka Zenke9, Noriko Yanagitani2, Jonathan Greenberg10, Fumiaki Kobayashi11, Yui Kawasaki11, Kiyotaka Yoh9 (1.National Cancer Center Hospital, Tokyo, Japan, 2.The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, 3.David Geffen School of Medicine at UCLA, Los Angeles, CA, USA, 4.Sarah Cannon Research Institute, Tennessee Oncology, PLLC, One Oncology, Nashville, TN, USA, 5.Virginia Cancer Specialists and US Oncology Research, Fairfax, VA, USA, 6.Massachusetts General Hospital, Boston, MA, USA, 7.Dana-Farber Cancer Institute, Boston, MA, USA, 8.The University of Texas MD Anderson Cancer Center, Houston, TX, USA, 9.National Cancer Center Hospital East, Chiba, Japan, 10.Daiichi Sankyo, Inc, Basking Ridge, NJ, USA, 11.Daiichi Sankyo Co, Ltd, Tokyo, Japan)